Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
- PMID: 35223428
- PMCID: PMC8857774
- DOI: 10.1016/j.idcr.2022.e01456
Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
Abstract
We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using Carestart™ malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.
Keywords: BNT162b2; Chronic malaria; CoVID-19 vaccine; Malaria; Plasmodium malariae.
© 2022 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
None.
References
-
- Boccolini D., Menegon M., Di Luca M., Toma L., Severini F., Marucci G., et al. Non-imported malaria in Italy: paradigmatic approaches and public health implications following an unusual cluster of cases in 2017. BMC Public Health. 2020;20(1):857. doi: 10.1186/s12889-020-08748-9. [PMID: 32503526; PMCID: PMC7275312] - DOI - PMC - PubMed
-
- Krogstad D.J. In: Mandell, Douglas and Bennett’s principles and practice of infectious disease. 4th ed. Mandell G.L., Bennett J.E., Dolin R., editors. Vol. 2. Churchill Livingstone; New York: 1995. Plasmodium species (malaria) pp. 2415–2427.
-
- Vinetz J.M., Li J., McCutchan T.F., Kaslow D.C. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med. 1998;338:367–371. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
